adrenergic receptor, alpha 2a |
AMINOSALICYLIC ACID |
Adrenergic alpha2A |
-17% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 14 |
AMITRIPTYLINE |
Protein Serine/Threonine Kinase, p38alpha |
-17% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 14 |
AMITRIPTYLINE |
Protein Serine/Threonine Kinase, p38alpha |
-17% |
NoneNone |
NoneNone |
View
|
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
AMITRIPTYLINE |
CYP450-2C9 Inhibition |
-17% |
NoneNone |
NoneNone |
View
|
cytochrome P450, family 2, subfamily C, polypeptide 9 |
AMITRIPTYLINE |
CYP450-2C9 Inhibition |
-17% |
NoneNone |
NoneNone |
View
|
acetylcholinesterase (YT blood group) |
RIFAMPIN |
Acetylcholinesterase |
-17% |
NoneNone |
NoneNone |
View
|
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase |
RIFAMPIN |
Acetylcholinesterase |
-17% |
NoneNone |
NoneNone |
View
|
acetylcholinesterase |
RIFAMPIN |
Acetylcholinesterase |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
AMLODIPINE |
Glutamate, NMDA, Agonism |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, NMDA2C |
AMLODIPINE |
Glutamate, NMDA, Agonism |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
AMLODIPINE |
Glutamate, NMDA, Agonism |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
AMLODIPINE |
Glutamate, NMDA, Agonism |
-17% |
NoneNone |
NoneNone |
View
|
N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) |
AMLODIPINE |
Glutamate, NMDA, Agonism |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B |
AMLODIPINE |
Glutamate, NMDA, Agonism |
-17% |
NoneNone |
NoneNone |
View
|
dopamine receptor D4 |
2-HYDROXYPROPYL-BETA-CYCLODEXTRIN |
Dopamine D4.2 |
-17% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2B |
STANNOUS FLUORIDE |
Serotonin 5-HT2B |
-17% |
NoneNone |
NoneNone |
View
|
FMS-like tyrosine kinase 1 |
SULFAMETHOXAZOLE |
Vascular Endothelinal Growth Factor (VEGF) |
-17% |
NoneNone |
NoneNone |
View
|
fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) |
SULFAMETHOXAZOLE |
Vascular Endothelinal Growth Factor (VEGF) |
-17% |
NoneNone |
NoneNone |
View
|
neuropeptide Y receptor Y1 |
AMLODIPINE |
Neuropeptide Y1 |
-17% |
NoneNone |
NoneNone |
View
|
calcitonin receptor |
SULINDAC |
Calcitonin |
-17% |
NoneNone |
NoneNone |
View
|
chemokine (C-C motif) receptor 5 |
ISONIAZID |
Chemokine CCR5 |
-17% |
NoneNone |
NoneNone |
View
|
chemokine (C-C motif) receptor 5 |
CHLOROXYLENOL |
Chemokine CCR5 |
-17% |
NoneNone |
NoneNone |
View
|
adenosine A2a receptor |
OMEPRAZOLE |
Adenosine A2A |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 5 |
STREPTOMYCIN |
Glutamate, Kainate |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 4 |
STREPTOMYCIN |
Glutamate, Kainate |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 3 |
STREPTOMYCIN |
Glutamate, Kainate |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 2 |
STREPTOMYCIN |
Glutamate, Kainate |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 1 |
STREPTOMYCIN |
Glutamate, Kainate |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1, gamma |
SULBACTAM |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1, delta |
SULBACTAM |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) |
SULBACTAM |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 alpha |
SULBACTAM |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type X, alpha |
SULBACTAM |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IX, alpha |
SULBACTAM |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage gated, type VIII, alpha |
SULBACTAM |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type VII, alpha |
SULBACTAM |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) |
SULBACTAM |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IV, beta |
SULBACTAM |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IV, alpha |
SULBACTAM |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type III, alpha |
SULBACTAM |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type II, beta |
SULBACTAM |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type II, alpha 2 |
SULBACTAM |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, beta |
SULBACTAM |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, alpha |
SULBACTAM |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IV, beta |
SULBACTAM |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) |
AZAURIDINE |
Glutamate, NMDA, Phencyclidine |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B |
AZAURIDINE |
Glutamate, NMDA, Phencyclidine |
-17% |
NoneNone |
NoneNone |
View
|
platelet-activating factor receptor |
KETOROLAC |
Platelet Activating Factor (PAF) |
-17% |
NoneNone |
NoneNone |
View
|
neuropeptide Y receptor Y1 |
AFLATOXIN B1 |
Neuropeptide Y1 |
-17% |
NoneNone |
NoneNone |
View
|
interleukin 8 receptor, alpha |
AFLATOXIN B1 |
Chemokine CXCR1(IL-8A) |
-17% |
NoneNone |
NoneNone |
View
|
angiotensin 1 converting enzyme 1 |
NOCODAZOLE |
Protease, Angiotensin Converting Enzyme |
-17% |
NoneNone |
NoneNone |
View
|
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
NOCODAZOLE |
Protease, Angiotensin Converting Enzyme |
-17% |
NoneNone |
NoneNone |
View
|
tachykinin receptor 1 |
AJMALINE |
Tachykinin NK1 |
-17% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 3 |
LACTIC ACID |
Protein Serine/Threonine Kinase, ERK1 |
-17% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 3 |
LACTIC ACID |
Protein Serine/Threonine Kinase, ERK1 |
-17% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 3a |
BIS(2-ETHYLHEXYL)PHTHALATE |
Serotonin 5-HT3 |
-17% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 3b |
BIS(2-ETHYLHEXYL)PHTHALATE |
Serotonin 5-HT3 |
-17% |
NoneNone |
NoneNone |
View
|
estrogen receptor 1 |
PIPERILATE ETHOBROMIDE |
Estrogen ERalpha |
-17% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 |
PIPERILATE ETHOBROMIDE |
GABAA, Chloride Channel, TBOB |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type II, alpha 2 |
ALFACALCIDOL |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, beta |
ALFACALCIDOL |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, alpha |
ALFACALCIDOL |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IV, beta |
ALFACALCIDOL |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel associated protein 1 |
ALFACALCIDOL |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel associated protein 2 |
ALFACALCIDOL |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type III, beta |
ALFACALCIDOL |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, alpha |
ALFACALCIDOL |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IX, alpha |
ALFACALCIDOL |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type VII, alpha |
ALFACALCIDOL |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
amiloride-sensitive cation channel 5, intestinal |
ALFACALCIDOL |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type III, beta |
ALFACALCIDOL |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type VIII, alpha polypeptide |
ALFACALCIDOL |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type XI, alpha |
ALFACALCIDOL |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, beta |
ALFACALCIDOL |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type 10, alpha polypeptide |
ALFACALCIDOL |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IV, alpha polypeptide |
ALFACALCIDOL |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type V, alpha polypeptide |
ALFACALCIDOL |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type II, beta |
ALFACALCIDOL |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 alpha |
ALFACALCIDOL |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 gamma |
ALFACALCIDOL |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 beta |
ALFACALCIDOL |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type 2, alpha 1 polypeptide |
ALFACALCIDOL |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type XI, alpha |
ALFACALCIDOL |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1, gamma |
ALFACALCIDOL |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1, delta |
ALFACALCIDOL |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) |
ALFACALCIDOL |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 alpha |
ALFACALCIDOL |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type X, alpha |
ALFACALCIDOL |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine receptor 6 |
ERGOCALCIFEROL |
Serotonin 5-HT6 |
-17% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2B |
SULFADIAZINE |
Serotonin 5-HT2B |
-17% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2C |
METHYL SALICYLATE |
Serotonin 5-HT2C |
-17% |
NoneNone |
NoneNone |
View
|
purinergic receptor P2X, ligand-gated ion channel, 1 |
TERFENADINE |
Purinergic P2X |
-17% |
NoneNone |
NoneNone |
View
|
purinergic receptor P2X, ligand-gated ion channel, 7 |
TERFENADINE |
Purinergic P2X |
-17% |
NoneNone |
NoneNone |
View
|
purinergic receptor P2X-like 1, orphan receptor |
TERFENADINE |
Purinergic P2X |
-17% |
NoneNone |
NoneNone |
View
|
protein kinase C, alpha |
DILTIAZEM |
Protein Serine/Threonine Kinase PKCalpha |
-17% |
NoneNone |
NoneNone |
View
|
protein kinase C, alpha |
DILTIAZEM |
Protein Serine/Threonine Kinase PKCalpha |
-17% |
NoneNone |
NoneNone |
View
|
elastase 2, neutrophil |
GLYCINE |
Protease, Elastase |
-17% |
NoneNone |
NoneNone |
View
|
angiotensin 1 converting enzyme 1 |
SULFAMETHAZINE |
Protease, Angiotensin Converting Enzyme |
-17% |
NoneNone |
NoneNone |
View
|
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
SULFAMETHAZINE |
Protease, Angiotensin Converting Enzyme |
-17% |
NoneNone |
NoneNone |
View
|
angiotensin 1 converting enzyme 1 |
TRICHLORMETHIAZIDE |
Protease, Angiotensin Converting Enzyme |
-17% |
NoneNone |
NoneNone |
View
|
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
TRICHLORMETHIAZIDE |
Protease, Angiotensin Converting Enzyme |
-17% |
NoneNone |
NoneNone |
View
|
angiotensin 1 converting enzyme 1 |
ZOLPIDEM |
Protease, Angiotensin Converting Enzyme |
-17% |
NoneNone |
NoneNone |
View
|
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
ZOLPIDEM |
Protease, Angiotensin Converting Enzyme |
-17% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 3B |
ALFACALCIDOL |
Phosphodiesterase PDE3 |
-17% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 3A |
ALFACALCIDOL |
Phosphodiesterase PDE3 |
-17% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, beta polypeptide 1 (muscle) |
4-NONYLPHENOL |
Nicotinic Acetylcholine, Central |
-17% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, alpha polypeptide 9 |
4-NONYLPHENOL |
Nicotinic Acetylcholine, Central |
-17% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, alpha polypeptide 10 |
4-NONYLPHENOL |
Nicotinic Acetylcholine, Central |
-17% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, epsilon polypeptide |
4-NONYLPHENOL |
Nicotinic Acetylcholine, Central |
-17% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, beta polypeptide 4 |
4-NONYLPHENOL |
Nicotinic Acetylcholine, Central |
-17% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, alpha polypeptide 5 |
4-NONYLPHENOL |
Nicotinic Acetylcholine, Central |
-17% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 2 |
PIROMIDIC ACID |
Muscarinic M2 |
-17% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 2 |
ANIRACETAM |
Muscarinic M2 |
-17% |
NoneNone |
NoneNone |
View
|
neuropeptide Y receptor Y2 |
SULFADIMETHOXINE |
Neuropeptide Y2 |
-17% |
NoneNone |
NoneNone |
View
|
neuropeptide Y receptor Y2 |
SULFADIMETHOXINE |
Neuropeptide Y2 |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
DIELDRIN |
Calcium Channel Type L, Benzothiazepine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
DIELDRIN |
Calcium Channel Type L, Benzothiazepine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
DIELDRIN |
Calcium Channel Type L, Benzothiazepine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
DIELDRIN |
Calcium Channel Type L, Benzothiazepine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
DIELDRIN |
Calcium Channel Type L, Benzothiazepine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
DIELDRIN |
Calcium Channel Type L, Benzothiazepine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
DIELDRIN |
Calcium Channel Type L, Benzothiazepine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
DIELDRIN |
Calcium Channel Type L, Benzothiazepine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
DIELDRIN |
Calcium Channel Type L, Benzothiazepine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
DIELDRIN |
Calcium Channel Type L, Benzothiazepine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
DIELDRIN |
Calcium Channel Type L, Benzothiazepine |
-17% |
NoneNone |
NoneNone |
View
|
DNA encoding receptor of vasoactive intestinal polypeptide |
ETODOLAC |
Vasoactive Intestinal Peptide VIP1 |
-17% |
NoneNone |
NoneNone |
View
|
protein kinase C, alpha |
MITOTANE |
Protein Serine/Threonine Kinase PKCalpha |
-17% |
NoneNone |
NoneNone |
View
|
protein kinase C, alpha |
MITOTANE |
Protein Serine/Threonine Kinase PKCalpha |
-17% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 1 |
ZIRCONIUM(IV) CHLORIDE |
Muscarinic M1 |
-17% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 2 |
DIELDRIN |
Muscarinic M2 |
-17% |
NoneNone |
NoneNone |
View
|
calcitonin receptor |
PROPYLTHIOURACIL |
Calcitonin |
-17% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor 2 |
LEVOFLOXACIN |
Leukotriene B4 |
-17% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor |
LEVOFLOXACIN |
Leukotriene B4 |
-17% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor |
LEVOFLOXACIN |
Leukotriene B4 |
-17% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor 2 |
LEVOFLOXACIN |
Leukotriene B4 |
-17% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 1b |
LEVODOPA |
Adrenergic alpha1B |
-17% |
NoneNone |
NoneNone |
View
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
LEVOCARNITINE |
Potassium Channel [KATP] |
-17% |
NoneNone |
NoneNone |
View
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 9 |
LEVOCARNITINE |
Potassium Channel [KATP] |
-17% |
NoneNone |
NoneNone |
View
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
LEVOCARNITINE |
Potassium Channel [KATP] |
-17% |
NoneNone |
NoneNone |
View
|
arginine vasopressin receptor 1A |
LEVOCARNITINE |
Vasopressin V1A |
-17% |
NoneNone |
NoneNone |
View
|
dopamine receptor D3 |
RISEDRONIC ACID |
Dopamine D3 |
-17% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
LIDOCAINE |
Cyclooxygenase COX-1 |
-17% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
LIDOCAINE |
Cyclooxygenase COX-1 |
-17% |
NoneNone |
NoneNone |
View
|
histamine receptor H 2 |
SULFADIMETHOXINE |
Histamine H2 |
-17% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
TROPISETRON |
Cyclooxygenase COX-1 |
-17% |
NoneNone |
NoneNone |
View
|
melanocortin 5 receptor |
RISPERIDONE |
Melanocortin MC5 |
-17% |
NoneNone |
NoneNone |
View
|
adenosine A1 receptor |
IRINOTECAN |
Adenosine A1 |
-17% |
NoneNone |
NoneNone |
View
|
bradykinin receptor, beta 2 |
DEXKETOPROFEN |
Bradykinin B2 |
-17% |
NoneNone |
NoneNone |
View
|
bradykinin receptor B2 |
DEXKETOPROFEN |
Bradykinin B2 |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
DOXIFLURIDINE |
Calcium Channel Type L, Benzothiazepine |
-17% |
NoneNone |
NoneNone |
View
|
histamine receptor H 2 |
FENOPROFEN |
Histamine H2 |
-17% |
NoneNone |
NoneNone |
View
|
opioid receptor, sigma 1 |
METFORMIN |
Sigma1 |
-17% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 3 |
MC 258717 |
Glycine, Strychnine-Sensitive |
-17% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 1 subunit |
MC 258717 |
Glycine, Strychnine-Sensitive |
-17% |
NoneNone |
NoneNone |
View
|
glycine receptor, beta subunit |
MC 258717 |
Glycine, Strychnine-Sensitive |
-17% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 2 subunit |
MC 258717 |
Glycine, Strychnine-Sensitive |
-17% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 3 |
INDINAVIR |
Glycine, Strychnine-Sensitive |
-17% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 1 subunit |
INDINAVIR |
Glycine, Strychnine-Sensitive |
-17% |
NoneNone |
NoneNone |
View
|
glycine receptor, beta subunit |
INDINAVIR |
Glycine, Strychnine-Sensitive |
-17% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 2 subunit |
INDINAVIR |
Glycine, Strychnine-Sensitive |
-17% |
NoneNone |
NoneNone |
View
|
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
INDINAVIR |
Serotonin Transporter |
-17% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-1A2 monooxygenase |
PANTHENOL |
CYP450-1A2 Inhibition |
-17% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 |
LORATADINE |
Cyclooxygenase COX-2 |
-17% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
LORATADINE |
Cyclooxygenase COX-2 |
-17% |
NoneNone |
NoneNone |
View
|
DNA encoding receptor of vasoactive intestinal polypeptide |
METHYSERGIDE |
Vasoactive Intestinal Peptide VIP1 |
-17% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 3a |
4-(PHENYLMETHYL)-1-[2-(TRIFLUOROMETHYL)BENZOYL]-PIPERIDINE |
Serotonin 5-HT3 |
-17% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 3b |
4-(PHENYLMETHYL)-1-[2-(TRIFLUOROMETHYL)BENZOYL]-PIPERIDINE |
Serotonin 5-HT3 |
-17% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-1A2 monooxygenase |
PENICILLIN G |
CYP450-1A2 Inhibition |
-17% |
NoneNone |
NoneNone |
View
|
protein phosphatase 3 (formerly 2B), catalytic subunit, alpha isoform (calcineurin A alpha) |
LIPOPOLYSACCHARIDE E. COLI O55:B5 |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
-17% |
NoneNone |
NoneNone |
View
|
protein phosphatase 3 (formerly 2B), catalytic subunit, beta isoform (calcineurin A beta) |
LIPOPOLYSACCHARIDE E. COLI O55:B5 |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
-17% |
NoneNone |
NoneNone |
View
|
protein phosphatase 3 (formerly 2B), catalytic subunit, gamma isoform (calcineurin A gamma) |
LIPOPOLYSACCHARIDE E. COLI O55:B5 |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
-17% |
NoneNone |
NoneNone |
View
|
protein phosphatase 3 (formerly 2B), catalytic subunit, gamma isoform (calcineurin A gamma) |
LIPOPOLYSACCHARIDE E. COLI O55:B5 |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
-17% |
NoneNone |
NoneNone |
View
|
protein phosphatase 3, catalytic subunit, beta isoform |
LIPOPOLYSACCHARIDE E. COLI O55:B5 |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
-17% |
NoneNone |
NoneNone |
View
|
bM410K19.2.2 (novel protein similar to extra-cellular matrix proteins and chondroitin sulfate proteoglycans, variant 2) (DBSS) |
LIPOPOLYSACCHARIDE E. COLI O55:B5 |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
-17% |
NoneNone |
NoneNone |
View
|
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
ALPRAZOLAM |
Adrenergic, Norepinephrine Transporter |
-17% |
NoneNone |
NoneNone |
View
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
MESTRANOL |
Protein Tyrosine Kinase, HER2 Receptor |
-17% |
NoneNone |
NoneNone |
View
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
MESTRANOL |
Protein Tyrosine Kinase, HER2 Receptor |
-17% |
NoneNone |
NoneNone |
View
|
adenosine A2a receptor |
MESTRANOL |
Adenosine A2A |
-17% |
NoneNone |
NoneNone |
View
|
dopamine receptor D3 |
TROMETHAMINE |
Dopamine D3 |
-17% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-1A2 monooxygenase |
SECNIDAZOLE |
CYP450-1A2 Inhibition |
-17% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2A |
PROGESTERONE |
Serotonin 5-HT2A |
-17% |
NoneNone |
NoneNone |
View
|
acetylcholinesterase (YT blood group) |
CAPTOPRIL |
Acetylcholinesterase |
-17% |
NoneNone |
NoneNone |
View
|
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase |
CAPTOPRIL |
Acetylcholinesterase |
-17% |
NoneNone |
NoneNone |
View
|
acetylcholinesterase |
CAPTOPRIL |
Acetylcholinesterase |
-17% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 3 |
CAPTOPRIL |
Glycine, Strychnine-Sensitive |
-17% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 1 subunit |
CAPTOPRIL |
Glycine, Strychnine-Sensitive |
-17% |
NoneNone |
NoneNone |
View
|
glycine receptor, beta subunit |
CAPTOPRIL |
Glycine, Strychnine-Sensitive |
-17% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 2 subunit |
CAPTOPRIL |
Glycine, Strychnine-Sensitive |
-17% |
NoneNone |
NoneNone |
View
|
purinergic receptor P2X, ligand-gated ion channel, 1 |
BETA-ESTRADIOL 3-BENZOATE |
Purinergic P2X |
-17% |
NoneNone |
NoneNone |
View
|
purinergic receptor P2X, ligand-gated ion channel, 7 |
BETA-ESTRADIOL 3-BENZOATE |
Purinergic P2X |
-17% |
NoneNone |
NoneNone |
View
|
purinergic receptor P2X-like 1, orphan receptor |
BETA-ESTRADIOL 3-BENZOATE |
Purinergic P2X |
-17% |
NoneNone |
NoneNone |
View
|
adenosine A1 receptor |
ALTRETAMINE |
Adenosine A1 |
-17% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 3a |
AMIFOSTINE |
Serotonin 5-HT3 |
-17% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 3b |
AMIFOSTINE |
Serotonin 5-HT3 |
-17% |
NoneNone |
NoneNone |
View
|
melanocortin 4 receptor |
PYROGALLOL |
Melanocortin MC4 |
-17% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, beta 2 |
3-ACETAMIDOPHENOL |
Adrenergic beta2 |
-17% |
NoneNone |
NoneNone |
View
|
dopamine receptor D1A |
INSULIN |
Dopamine D1 |
-17% |
NoneNone |
NoneNone |
View
|
angiotensin II receptor, type 2 |
ALTRETAMINE |
Angiotensin AT2 |
-17% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-2C19 monooxygenase |
INSULIN |
CYP450-2C19 Inhibition |
-17% |
NoneNone |
NoneNone |
View
|